PHARMA-BIO SERV, INC. Debt Securities, Available-for-sale, Realized Gain (Loss)
PHARMA-BIO SERV, INC. (PBSV) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of -$36.61 thousand for the 3-month period ending 2024-04-30, per its 10-Q filed 2024-06-14.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2024-06-14
- PHARMA-BIO SERV, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-04-30 was -$36.61K, a 153.75% decline year-over-year.
- PHARMA-BIO SERV, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-01-31 was $32.96K, a 73.88% decline year-over-year.
- PHARMA-BIO SERV, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2023-04-30 was $68.10K.
- PHARMA-BIO SERV, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2023-01-31 was $126.15K.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month |
|---|---|---|
| 2024-04-30 | -$36.61K 10-Q · filed 2024-06-14 | -$3.65K 10-Q · filed 2024-06-14 |
| 2024-01-31 | $32.96K 10-Q · filed 2024-03-18 | |
| 2023-04-30 | $68.10K 10-Q · filed 2024-06-14 | $194.25K 10-Q · filed 2024-06-14 |
| 2023-01-31 | $126.15K 10-Q · filed 2024-03-18 |